Global Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Peptides Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Peptides report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Peptides market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Diabetes and Infectious Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Peptides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Peptides key manufacturers include Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited and Celon Laboratories Pvt. Ltd., etc. Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited are top 3 players and held % sales share in total in 2022.
Peptides can be divided into Insulin, Teriparatide, Liraglutide and Leuprolide, etc. Insulin is the mainstream product in the market, accounting for % sales share globally in 2022.
Peptides is widely used in various fields, such as Diabetes, Infectious Diseases, Cancer and Osteoporosis, etc. Diabetes provides greatest supports to the Peptides industry development. In 2022, global % sales of Peptides went into Diabetes filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech(P) Limited
Segment by Type
Insulin
Teriparatide
Liraglutide
Leuprolide
Diabetes
Infectious Diseases
Cancer
Osteoporosis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Peptides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Peptides introduction, etc. Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Peptides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Peptides industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Peptides key manufacturers include Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited, Troikaa Pharmaceuticals Ltd., Biological E Limited, Bharat Biotech, Samarth Life Sciences Pvt. Ltd., VHB Life Sciences Limited and Celon Laboratories Pvt. Ltd., etc. Cipla Ltd., Emcure Pharmaceuticals Pvt. Ltd., Gland Pharma Limited are top 3 players and held % sales share in total in 2022.
Peptides can be divided into Insulin, Teriparatide, Liraglutide and Leuprolide, etc. Insulin is the mainstream product in the market, accounting for % sales share globally in 2022.
Peptides is widely used in various fields, such as Diabetes, Infectious Diseases, Cancer and Osteoporosis, etc. Diabetes provides greatest supports to the Peptides industry development. In 2022, global % sales of Peptides went into Diabetes filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Cipla Ltd.
Emcure Pharmaceuticals Pvt. Ltd.
Gland Pharma Limited
Troikaa Pharmaceuticals Ltd.
Biological E Limited
Bharat Biotech
Samarth Life Sciences Pvt. Ltd.
VHB Life Sciences Limited
Celon Laboratories Pvt. Ltd.
United Biotech(P) Limited
Segment by Type
Insulin
Teriparatide
Liraglutide
Leuprolide
Segment by Application
Diabetes
Infectious Diseases
Cancer
Osteoporosis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptides market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Peptides, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Peptides industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Peptides in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Peptides introduction, etc. Peptides Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Peptides market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.